Skip to main content

Day: November 20, 2024

KALDVIK AS (KLDVK): Q3 2024 Results

KALDVIK AS (KLDVK) reports Operating income in Q3 amounted to EURm 24.5 (EURm 2.1), while the operating profit before fair value adjustment of biomass and production tax was EURm 2.1 (EURm 0.3). Harvest amounted to 3.798 tonnes in Q3 2024 (193 tonnes) Web cast will be at 11:00 (CET)/ 10:00 Icelandic time on 20 November 2024 on the following link on Teams: https://t.ly/4YB_C Attached is the presentation and report for Q3 2024. Kaldvik, 20 November 2024 Contacts: Robert Robertsson, CFO of KALDVIK AS: +354 843 0086(mobile) This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentsKaldvik_Q3_2024_PresentationKaldvik_Q3_2024_Report

Continue reading

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

Phase 2 data establish proof-of-concept of efgartigimod SC in myositisEnrollment to continue in Phase 3 across all three subtypes (IMNM, ASyS, DM) under evaluation in ALKIVIAPotential for efgartigimod SC to be first targeted approach for myositis patients who have limited treatment optionsNovember 20, 2024, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced the decision to continue development of efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in the ongoing Phase 2/3 ALKIVIA study in adults with idiopathic inflammatory myopathies (IIM or myositis), following analysis of topline data from the Phase 2 portion of the study. ALKIVIA will continue...

Continue reading

Fairfax Launches C$700 Million Senior Notes Offering

Not for distribution to U.S. news wire services or dissemination in the United States. The base shelf prospectus is accessible, and the shelf prospectus supplement for this offering will be accessible within two business days, through SEDAR+ TORONTO, Nov. 19, 2024 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it intends to offer (i) C$450 million in aggregate principal amount of Senior Notes due 2034 (the “2034 Notes”) to be priced at C$99.929 per C$100 principal amount, and (ii) C$250 million in aggregate principal amount of Senior Notes due 2054 (the “2054 Notes” and, together with the 2034 Notes, the “Senior Notes”) to be priced at C$100 per C$100 principal amount (the “Offering”). The Senior Notes will be offered through a syndicate of dealers to be led by BMO Nesbitt...

Continue reading

Colliers’ 2025 Global Investor Outlook reveals renewed investor optimism in commercial real estate as pricing stabilizes

Colliers 2025 Global Investor OutlookColliers’ fifth annual report synthesizes views from senior capital markets experts and research data to provide a comprehensive look at commercial real estate investment trends and the most promising opportunities in the year ahead.Broad momentum across asset classes, private wealth to reshape capital flows LONDON and TORONTO, Nov. 19, 2024 (GLOBE NEWSWIRE) — Leading global diversified professional services company Colliers released its 2025 Global Investor Outlook, revealing renewed investor optimism and confidence that the commercial property market has moved past an inflection point following two years of muted transactions. On the back of subsiding inflation, lower interest rates, an improved economic outlook and expansive fundraising, Colliers anticipates a new market environment...

Continue reading

Pyrogen Testing Market to Surpass Valuation of USD 4.10 Billion by 2031 | SkyQuest Technology

The pyrogen testing market is projected to witness significant growth over the forthcoming years owing to the growing digitalization and automation in testing processes and the expansion of biologics and biopharmaceuticals. Westford, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global pyrogen testing market size will reach a value of USD 4.10 Billion by 2031, with a CAGR of 13.4% during the forecast period (2024-2031). Growing demand for pyrogen testing products in the biotechnology and pharmaceutical industries is one of the key factors driving the expansion of the market. The global pyrogen testing market products is anticipated to increase due to the rapidly expanding pharmaceutical and biotechnology sectors as well as the growing number of innovative treatments being introduced. One of the key elements driving...

Continue reading

Bioremediation Market to Reach USD 31.91 Billion by 2031 | SkyQuest Technology

Rapidly increasing environmental pollution and contamination due to malpractices of humans are projected to primarily augment the demand for bioremediation across the forecast period. Westford, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Bioremediation Market Share will reach a value of USD 31.91 Billion by 2031, with a CAGR of 9.93% during the forecast period (2024-2031). Throughout the projection period, the increasing levels of human wrongdoing-induced environmental contamination and pollution are expected to chiefly augment the demand for bioremediation. The bioremediation market growth is further going to be facilitated by the strict environmental conservation laws implemented and fresh initiatives for restoring the environment and undoing the harms incurred due to human activities during the projection...

Continue reading

Duos Technologies Group Reports Improved Third Quarter 2024 Results

Revenue increased 112% to $3.24 million in the quarter of which almost 50% was related to recurring revenue services and consulting with increased gross margin and decreased operating expenses. JACKSONVILLE, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) — Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), reported financial results for the third quarter (“Q3 2024”) ended September 30, 2024.Third Quarter 2024 and Recent Operational HighlightsDelivered and installed Edge Data Center for Amtrak at the Secaucus location. Construction work continues at the site. Received more than $1.4 million in contract modifications at Amtrak including renewal of the subscription utilizing three portals for long-distance passenger trains. Initial discussions for future sites in progress. Expanded investment in new subsidiary, “Duos...

Continue reading

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of October 2024

DENVER, Nov. 19, 2024 (GLOBE NEWSWIRE) — ArrowMark Financial Corp., (NASDAQ: BANX) (“ArrowMark Financial”), today announced that BANX’s estimated and unaudited Net Asset Value (“NAV”) as of October 31, 2024, was $22.02. This estimated NAV is not a comprehensive statement of our financial condition or results for the month ended October 31, 2024. About ArrowMark Financial Corp. ArrowMark Financial Corp. is an SEC registered non-diversified, closed-end fund listed on the NASDAQ Global Select Market under the symbol “BANX.” Its investment objective is to provide shareholders with current income. BANX pursues its objective by investing primarily in regulatory capital securities of financial institutions. BANX is managed by ArrowMark Asset Management, LLC. To learn more, visit ir.arrowmarkfinancialcorp.com, or contact Destra...

Continue reading

CORRECTION – DT Midstream Announces $1.2 Billion Acquisition of Strategic Midwest FERC-Regulated Natural Gas Pipelines

In a release issued under the same headline earlier today by DT Midstream, Inc. (NYSE: DTM), please note that in the “Conference Call” paragraph of the release, the call time should be 9:30 a.m. ET (8:30 a.m. CT) on Wednesday, November 20, rather than 8:00 a.m. ET (7:00 a.m. CT) as previously stated. The corrected release follows: DT Midstream Announces $1.2 Billion Acquisition of Strategic Midwest FERC-Regulated Natural Gas PipelinesThree regulated natural gas transmission pipelines with total capacity of more than 3.7 Bcf/d across the Upper Midwest Premier assets with a high-quality demand-pull customer base Connected to DTM’s existing assets and strategically located to take advantage of strong power demand fundamentalsDETROIT, Nov. 19, 2024 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) today announced that...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.